Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 48, 2019 - Issue 1
130
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Comparison of the Percentage of Regulatory T cells and their p-STAT5 Expression in Allergic and Non-Allergic Common Variable Immunodeficiency Patients

, ORCID Icon, , & ORCID Icon

References

  • Agata Y, Kawasaki A, Nishimura H, et al. (1996). Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int immunol, 8, 765–772.
  • Aghamohammadi A, Pouladi N, Parvaneh N, et al. (2006). Mortality and morbidity in common variable immunodeficiency. J Trop Pediatr, 53, 32–38. doi:10.1093/tropej/fml077.
  • Agondi R, Barros M, Rizzo L, et al. (2010). Allergic asthma in patients with common variable immunodeficiency. Allergy, 65, 510–515. doi:10.1111/j.1398-9995.2009.02211.x.
  • Arandi N, Mirshafiey A, Abolhassani H, Jeddi‐Tehrani M, Edalat R,Sadeghi B, et al. 2013. Frequency and expression of inhibitory markers of CD4+ CD25+ FOXP3+ regulatory T cells in patients with common variable immunodeficiency. Scand J Immunol, 77, 405–412.
  • Arumugakani G, Wood PM, Carter CR. (2010). Frequency of Treg cells is reduced in CVID patients with autoimmunity and splenomegaly and is associated with expanded CD21 lo B lymphocytes. J clin Immunol, 30, 292–300. doi:10.1007/s10875-009-9351-3.
  • Azizi G, Rezaei N, Kiaee F, et al. (2016). T-Cell Abnormalities in Common Variable Immunodeficiency. J Investig Allergol Clin Immunol, 26, 233–243. doi:10.18176/jiaci.0069.
  • Bacher P, Heinrich F, Stervbo U, et al. (2016). Regulatory T cell specificity directs tolerance versus allergy against aeroantigens in humans. Cell, 167, 1067–1078. doi:10.1016/j.cell.2016.09.050.
  • Bateman E, Ayers L, Sadler R, et al. (2012). T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Experi Immunol, 170, 202–211. doi:10.1111/j.1365-2249.2012.04643.x.
  • Brusko TM, Hulme MA, Myhr CB, et al. (2007). Assessing the in vitro suppressive capacity of regulatory T cells. Immunol Invest, 36, 607–628. doi:10.1080/08820130701790368.
  • Cunill V, Clemente A, Lanio N, et al. (2017). Follicular T cells from smB− common Variable immunodeficiency Patients are skewed Toward a Th1 Phenotype. Front Immunol, 8, 174. doi:10.3389/fimmu.2017.00174.
  • Cunningham-Rundles C, Bodian C. (1999). Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol, 92, 34–48. doi:10.1006/clim.1999.4725.
  • Dadkhah M, Aghamohammadi A, Movahedi M, Gharagozlou M. (2015). Atopic Manifestations: dermatitis, Allergic Rhinitis and Asthma in Patients With Hypogammaglobulinemia. Iran j pediatr, 25. doi:10.5812/ijp.
  • Egawa M, Kanegane H, Imai K, et al. (2018). Intravenous immunoglobulin (IVIG) efficiency in women with common variable immunodeficiency (CVID) decreases significantly during pregnancy. J Matern Fetal Neonatal Med, 1–5. doi:10.1080/14767058.2018.1455824.
  • Fleischman A, Hershfield MS, Toutain S, et al. (1998). Adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency in common variable immunodeficiency. Clin diagn lab immunol, 5, 399–400.
  • Genre J, Errante P, Kokron C, et al. (2009). Reduced frequency of CD4+ CD25HIGH FOXP3+ cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: A link to autoimmunity? Clin Immunol, 132, 215–221. doi:10.1016/j.clim.2009.03.519.
  • Grace PY, Chiang D, Song SJ, et al. (2009). Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease. Clin immunol, 131, 240–253. doi:10.1016/j.clim.2008.12.006.
  • Horn, J, Manguiat A, Berglund L, Knerr V, Tahami F, Grimbacher B, et al. (2009). Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency. Clin Experi Immunol, 156, 446–454. doi:10.1111/j.1365-2249.2009.03913.x.
  • Larche M. (2007). Regulatory T cells in allergy and asthma. Chest, 132, 1007–1014. doi:10.1378/chest.06-2434.
  • Lesiak, A, Smolewski P, Sobolewska‐Sztychny D, Sysa‐Jedrzejowska A, Narbutt J. (2012). The Role of T‐Regulatory Cells and Toll‐Like Receptors 2 and 4 In Atopic Dermatitis. Scand J Immunol, 76, 405–410. doi:10.1111/j.1365-3083.2012.02739.x.
  • Melo KM, Carvalho KI, Bruno FR, et al. (2009). A decreased frequency of regulatory T cells in patients with common variable immunodeficiency. PloS one, 4, e6269. doi:10.1371/journal.pone.0006269.
  • Nadeau K, Hwa V, Rosenfeld RG. (2011). STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease. J Pediatr, 158, 701–708. doi:10.1016/j.jpeds.2010.12.042.
  • Nava K, Ordoñez-Rueda D, Sarukhán A, Chávez-Rios JR, García-Zepeda EA, Soldevila G. (2009). A Specific Signalling Signature Characterizes the Development of Naturally Occurring and Antigen-Specific Regulatory T Cells. Immunol Invest, 38, 851–867. doi:10.3109/08820130903301055.
  • Özcan C, Metin A, Erkocoglu M, Kocabas CN. (2014). Allergic diseases in children with primary immunodeficiencies. Turk J Pediatr, 56, 41.
  • Palomares O, Yaman G, Azkur AK, et al. (2010). Role of Treg in immune regulation of allergic diseases. Eur j immunol, 40, 1232–1240. doi:10.1002/eji.200940045.
  • Paquin-Proulx D, Santos BA, Carvalho KI, et al. (2013). IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID. PloS One, 8, e75199. doi:10.1371/journal.pone.0075199.
  • Rezaei N, Aghamohammadi A, Kardar G, et al. (2008a). T-helper 1 and 2 cytokine assay in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol, 18, 449–453.
  • Rezaei N, Haji-Molla-Hoseini M, Aghamohammadi A, et al. (2008b). Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications. J Clin Immunol, 28, 78–84. doi:10.1007/s10875-007-9135-6.
  • Sadeghi B, Abolhassani H, Naseri A, et al. (2015). Economic burden of common variable immunodeficiency: annual cost of disease. Exp Rev Clin Immunol, 11, 681–688. doi:10.1586/1744666X.2015.1029457.
  • Strickland DH, Holt PG. (2011). T regulatory cells in childhood asthma. Trend Immunol, 32, 420–427. doi:10.1016/j.it.2011.06.010.
  • Unger S, Seidl M, Van Schouwenburg P, et al. (2017). The TH1 phenotype of follicular helper T cells indicates an IFN-γ–associated immune dysregulation in patients with CD21low common variable immunodeficiency. J Allergy Clin Immunol,141,730–740.
  • Westh L, Mogensen TH, Dalgaard LS, et al. (2017). Identification and Characterization of a Nationwide Danish Adult Common Variable Immunodeficiency Cohort. Scand Immunol, 85, 450–461. doi:10.1111/sji.12551.
  • Williams CM, Rahman S, Hubeau C, Ma H-L. (2012). Cytokine pathways in allergic disease. Toxicol pathol, 40, 205–215. doi:10.1177/0192623311430694.
  • Wu K, Bi Y, Sun K, Xia J, Wang Y, Wang C. (2008). Suppression of Allergic Inflammation by Allergen‐DNA‐modified Dendritic Cells Depends on the Induction of Foxp3+ Regulatory T Cells. Scand J Immunol, 67, 140–151. doi:10.1111/j.1365-3083.2007.02050.x.
  • Yazdani R, Heydari A, Azizi G, Abolhassani H, Aghamohammadi A. (2016). Asthma and Allergic Diseases in a Selected Group of Patients With Common Variable Immunodeficiency. J Invest allergol Clin Immunol, 26, 209–211. doi:10.18176/jiaci.0062.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.